Skip to main content
. 2023 Jan 21;29(3):487–502. doi: 10.3748/wjg.v29.i3.487

Figure 1.

Figure 1

Interplay between coronavirus disease 2019 and metabolic-associated fatty liver disease. COVID-19: Coronavirus disease 2019; MAFLD: Metabolic-associated fatty liver disease; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.